Your browser doesn't support javascript.
loading
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
Tian, Hao; Qu, Man; Zhang, Guozhi; Yuan, Long; Shi, Qiyun; Wang, Yinhuan; Yang, Ying; Zhang, Yi; Qi, Xiaowei.
Affiliation
  • Tian H; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Qu M; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Zhang G; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Yuan L; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Shi Q; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Wang Y; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Yang Y; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Zhang Y; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
  • Qi X; Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China.
Oncologist ; 28(7): e534-e541, 2023 07 05.
Article in En | MEDLINE | ID: mdl-37120151

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article